Results 111 to 120 of about 26,737 (201)

Successful Sequential and Additive Drug Challenge With Rapid Oral Desensitization in Rifampicin-Induced Fever. [PDF]

Respirol Case Rep
Guo XY, Zois C.
europepmc   +1 more source

[A severe side effect of antitubercular therapy: pyrazinamide induced thrombocytopenia].

, 2008
International audienceThe haematological side effects of antitubercular drugs are not well known. We report the observation of a patient who received Rifater for the treatment of pulmonary tuberculosis. After one month of treatment, he developed an acute
N'Guyen Huy Thuy, G., Berard, H., Legodec, J., Chouaid, C., Rocher, F., Roseau, J.-B.   +5 more
core  

A Case of Peritoneal Dialysis-Associated Peritonitis Due to <i>Mycobacterium tuberculosis</i>: Case Report and Review of the Literature. [PDF]

Case Rep Infect Dis
Wick JM, Cooper JD.
europepmc   +1 more source

A Rare Dual Complication of First-Line Anti-tubercular Therapy: A Case Report of Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome and Ethambutol-Induced Optic Neuropathy. [PDF]

Cureus
Kundu K, Alazzawi A.
europepmc   +1 more source

Clinical efficacy and pharmacokinetic study of antituberculosis treatment in patients with end-stage renal disease undergoing hemodialysis. [PDF]

Asian Biomed (Res Rev News)
Song W, Yang Z, Zhao Y, Liu B, Li M, Du W, Niu N, Jia J.   +7 more
europepmc   +1 more source

Impact of undernutrition and diabetes on the pharmacokinetics of first-line anti-TB drugs. [PDF]

IJTLD Open
Ezhumalai K, Rao PS, Babu SP, Jeyakumar SM, Bollinger RC, Heysell SK, Tornheim JA, Narasimhan PB, Thangakunam B, Paradkar M, Christopher DJ, Gaikwad S, Viswanathan V, Kornfeld H, Ellner JJ, Salgame P, Horsburgh CR, Gupte AN, Gupta A, Mave V, Sarkar S, Perumal K B, Sinha P, RePORT India Consortium.   +23 more
europepmc   +1 more source

National genomic survey of drug-resistance and multi-jurisdictional clusters of <i>Mycobacterium tuberculosis</i> in Australia 2015-2023. [PDF]

Lancet Reg Health West Pac
Webb JR, Sim E, Horan K, Selway C, Andersson P, Moss S, Pang S, Bainomugisa A, Zahedi A, Denholm JT, Martinez E, Pandey S, Globan M, Crighton T, Meumann EM, Menouhos D, Baird RW, Sherry NL, Kennedy K, Cooley L, Leong L, Slogget C, Seemann T, Coulter C, Jennison AV, Sintchenko V, Howden BP, Australian Pathogen Genomics program.   +27 more
europepmc   +1 more source

Inflammation Precedes Paradoxical Reactions in HIV-Negative Patients With Pulmonary Tuberculosis. [PDF]

Open Forum Infect Dis
Kurver L, Klein Teeselink E, Koele SE, Hanemaaijer N, Lemson A, Bosteels C, Carpaij N, Ardiansyah E, Vullinghs R, Magis-Escurra C, van Weerdenburg IJM, Geurts B, Schalekamp S, den Broeder AA, Te Brake L, Arts RJW, van Ingen J, Hoefsloot W, Aarnoutse R, van Arkel C, van Laarhoven A.   +20 more
europepmc   +1 more source

Concurrent Rasmussen aneurysm and pulmonary embolism in a patient with cavitary pulmonary tuberculosis. [PDF]

CMAJ
Shah D, Lau A, Barrie J, Pi Y, Long R.
europepmc   +1 more source

Analysis of the impact of national centralized volume-based procurement drug policy on the market dynamics of tuberculosis drugs. [PDF]

BMC Health Serv Res
Yang J, Yu X, Yao Y, Zhao W, Chen Y, Wang Z, Xu M.   +6 more
europepmc   +1 more source